These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 15073680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
    Goodfellow IG, Evans DJ, Blom AM, Kerrigan D, Miners JS, Morgan BP, Spiller OB.
    J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
    [Abstract] [Full Text] [Related]

  • 3. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S, Dieringer B, Klopfleisch R, Savvatis K, Van Linthout S, Pryshliak M, Tschöpe C, Klingel K, Kurreck J, Beling A, Fechner H.
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [Abstract] [Full Text] [Related]

  • 4. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
    Dörner A, Grunert HP, Lindig V, Chandrasekharan K, Fechner H, Knowlton KU, Isik A, Pauschinger M, Zeichhardt H, Schultheiss HP.
    J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
    [Abstract] [Full Text] [Related]

  • 5. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK, Choi JH, Nam JH, Gil CO, Shin JO, Yun SH, Kim DK, Jeon ES.
    Cardiovasc Res; 2006 Aug 01; 71(3):517-26. PubMed ID: 16806133
    [Abstract] [Full Text] [Related]

  • 6. Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice.
    Yanagawa B, Spiller OB, Choy J, Luo H, Cheung P, Zhang HM, Goodfellow IG, Evans DJ, Suarez A, Yang D, McManus BM.
    Lab Invest; 2003 Jan 01; 83(1):75-85. PubMed ID: 12533688
    [Abstract] [Full Text] [Related]

  • 7. Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity.
    Zhang K, Yu H, Xie W, Xu Z, Zhou S, Huang C, Sheng H, He X, Xiong J, Qian G.
    J Biotechnol; 2013 Apr 15; 164(4):461-8. PubMed ID: 23376619
    [Abstract] [Full Text] [Related]

  • 8. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
    Pinkert S, Pryshliak M, Pappritz K, Knoch K, Hazini A, Dieringer B, Schaar K, Dong F, Hinze L, Lin J, Lassner D, Klopfleisch R, Solimena M, Tschöpe C, Kaya Z, El-Shafeey M, Beling A, Kurreck J, Van Linthout S, Klingel K, Fechner H.
    Cardiovasc Res; 2020 Aug 01; 116(10):1756-1766. PubMed ID: 31598635
    [Abstract] [Full Text] [Related]

  • 9. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
    Yu JZ, Wilson JE, Wood SM, Kandolf R, Klingel K, Yang D, McManus BM.
    Cardiovasc Pathol; 1999 Aug 01; 8(2):93-102. PubMed ID: 10724506
    [Abstract] [Full Text] [Related]

  • 10. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
    Stein EA, Pinkert S, Becher PM, Geisler A, Zeichhardt H, Klopfleisch R, Poller W, Tschöpe C, Lassner D, Fechner H, Kurreck J.
    J Infect Dis; 2015 Feb 15; 211(4):613-22. PubMed ID: 25193982
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
    Selinka HC, Wolde A, Pasch A, Klingel K, Schnorr JJ, Küpper JH, Lindberg AM, Kandolf R.
    J Med Virol; 2002 Jun 15; 67(2):224-33. PubMed ID: 11992583
    [Abstract] [Full Text] [Related]

  • 12. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P.
    J Med Virol; 2007 Sep 15; 79(9):1334-42. PubMed ID: 17607777
    [Abstract] [Full Text] [Related]

  • 13. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
    Liu JY, Wang SM, Chen IC, Yu CK, Liu CC.
    Pathog Dis; 2013 Jul 15; 68(2):52-60. PubMed ID: 23620416
    [Abstract] [Full Text] [Related]

  • 14. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.
    Zautner AE, Körner U, Henke A, Badorff C, Schmidtke M.
    J Virol; 2003 Sep 15; 77(18):10071-7. PubMed ID: 12941917
    [Abstract] [Full Text] [Related]

  • 15. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
    Pinkert S, Westermann D, Wang X, Klingel K, Dörner A, Savvatis K, Grössl T, Krohn S, Tschöpe C, Zeichhardt H, Kotsch K, Weitmann K, Hoffmann W, Schultheiss HP, Spiller OB, Poller W, Fechner H.
    Circulation; 2009 Dec 08; 120(23):2358-66. PubMed ID: 19933937
    [Abstract] [Full Text] [Related]

  • 16. Colchicine aggravates coxsackievirus B3 infection in mice.
    Smilde BJ, Woudstra L, Fong Hing G, Wouters D, Zeerleder S, Murk JL, van Ham M, Heymans S, Juffermans LJ, van Rossum AC, Niessen HW, Krijnen PA, Emmens RW.
    Int J Cardiol; 2016 Aug 01; 216():58-65. PubMed ID: 27140338
    [Abstract] [Full Text] [Related]

  • 17. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
    Tschöpe C, Müller I, Xia Y, Savvatis K, Pappritz K, Pinkert S, Lassner D, Heimesaat MM, Spillmann F, Miteva K, Bereswill S, Schultheiss HP, Fechner H, Pieske B, Kühl U, Van Linthout S.
    Circ Heart Fail; 2017 Sep 01; 10(9):. PubMed ID: 28912259
    [Abstract] [Full Text] [Related]

  • 18. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
    Shi Y, Chen C, Lisewski U, Wrackmeyer U, Radke M, Westermann D, Sauter M, Tschöpe C, Poller W, Klingel K, Gotthardt M.
    J Am Coll Cardiol; 2009 Apr 07; 53(14):1219-26. PubMed ID: 19341864
    [Abstract] [Full Text] [Related]

  • 19. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
    Jiang Y, Zhu R, Luo L, Mu Q, Zhu Y, Luo H, Zou X, Shen X.
    Intervirology; 2015 Apr 07; 58(6):343-9. PubMed ID: 26829552
    [Abstract] [Full Text] [Related]

  • 20. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
    Cheung PK, Yuan J, Zhang HM, Chau D, Yanagawa B, Suarez A, McManus B, Yang D.
    J Med Virol; 2005 Nov 07; 77(3):414-24. PubMed ID: 16173012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.